{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
    },
    "document_metadata": {
      "authors": "Yojana Gadiya",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Hypoxia and Inflammation as a Consequence of β-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "NCIT": "^C\\d+$",
      "OMIT": "^\\d{7}$",
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/3c93a65dc48e6786fe29ae55aa36cf9a902fe8c6/export/conso-names.belns",
      "DOID": "https://raw.githubusercontent.com/pharmacome/conso/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns",
      "EFO": "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/conso/f02c6ad4a4791a8ed45448513b9de8c8f1b00c87/external/mesh-names.belns"
    },
    "path": "hpoxia/russo2019.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "A constant feature of amyloidoses is the progressive accumulation of β-fibrils in the intra- and extracellular space of involved tissues and organs as reported in Figure 1.",
      "key": "0129648476b476a9a30f4b64b2473a18",
      "line": 82,
      "object": {
        "location": {
          "name": "cytosol",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 97,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "A constant feature of amyloidoses is the progressive accumulation of β-fibrils in the intra- and extracellular space of involved tissues and organs as reported in Figure 1.",
      "key": "a633327d6eee8807126d1c3bfed266c5",
      "line": 83,
      "object": {
        "location": {
          "name": "nucleus",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 97,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "A constant feature of amyloidoses is the progressive accumulation of β-fibrils in the intra- and extracellular space of involved tissues and organs as reported in Figure 1.",
      "key": "582af1e20bdf4f1e45d44312e44c8b58",
      "line": 84,
      "object": {
        "location": {
          "name": "endoplasmic reticulum",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 97,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "A constant feature of amyloidoses is the progressive accumulation of β-fibrils in the intra- and extracellular space of involved tissues and organs as reported in Figure 1.",
      "key": "8f79624929afc4fb7fc22b18d886a066",
      "line": 85,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 97,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "A constant feature of amyloidoses is the progressive accumulation of β-fibrils in the intra- and extracellular space of involved tissues and organs as reported in Figure 1.",
      "key": "c25a993216a1329faa276e29646c7d1f",
      "line": 86,
      "object": {
        "location": {
          "name": "extracellular space",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 97,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "A constant feature of amyloidoses is the progressive accumulation of β-fibrils in the intra- and extracellular space of involved tissues and organs as reported in Figure 1.",
      "key": "65e11fd457bda60bd7582c7c4358eb8c",
      "line": 87,
      "object": {
        "location": {
          "name": "Plasma",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 97,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Systemic amyloidoses are characterized by the deposition of culprit proteins such as immunoglobulin light chains (intact or fragments) and many acute-phase proteins (SAA, transthyretin, fibrinogen α-chain, β2-macroglobulin, lysozyme, and gelsolin) [1, 21].",
      "key": "91d4ae87d44635c223f1bcc1bfa4bd9f",
      "line": 135,
      "relation": "increases",
      "source": 97,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Systemic amyloidoses are characterized by the deposition of culprit proteins such as immunoglobulin light chains (intact or fragments) and many acute-phase proteins (SAA, transthyretin, fibrinogen α-chain, β2-macroglobulin, lysozyme, and gelsolin) [1, 21].",
      "key": "a11c5332fe2022b5ffec8a852bae59d3",
      "line": 136,
      "relation": "increases",
      "source": 97,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Systemic amyloidoses are characterized by the deposition of culprit proteins such as immunoglobulin light chains (intact or fragments) and many acute-phase proteins (SAA, transthyretin, fibrinogen α-chain, β2-macroglobulin, lysozyme, and gelsolin) [1, 21].",
      "key": "698c23a535f4fc3d2737b2c32bbc38d4",
      "line": 137,
      "relation": "increases",
      "source": 97,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Systemic amyloidoses are characterized by the deposition of culprit proteins such as immunoglobulin light chains (intact or fragments) and many acute-phase proteins (SAA, transthyretin, fibrinogen α-chain, β2-macroglobulin, lysozyme, and gelsolin) [1, 21].",
      "key": "408ad66ee0f9346f5af82458eafc3cae",
      "line": 138,
      "relation": "increases",
      "source": 97,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Systemic amyloidoses are characterized by the deposition of culprit proteins such as immunoglobulin light chains (intact or fragments) and many acute-phase proteins (SAA, transthyretin, fibrinogen α-chain, β2-macroglobulin, lysozyme, and gelsolin) [1, 21].",
      "key": "3577b49b536e85fe06c5a7353768ac66",
      "line": 139,
      "relation": "increases",
      "source": 97,
      "target": 63
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Systemic amyloidoses are characterized by the deposition of culprit proteins such as immunoglobulin light chains (intact or fragments) and many acute-phase proteins (SAA, transthyretin, fibrinogen α-chain, β2-macroglobulin, lysozyme, and gelsolin) [1, 21].",
      "key": "352de7289d13792ced0adb4800875764",
      "line": 140,
      "relation": "increases",
      "source": 97,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Systemic amyloidoses are characterized by the deposition of culprit proteins such as immunoglobulin light chains (intact or fragments) and many acute-phase proteins (SAA, transthyretin, fibrinogen α-chain, β2-macroglobulin, lysozyme, and gelsolin) [1, 21].",
      "key": "a0b205f716d7e8fda93782eafb55b83f",
      "line": 141,
      "relation": "increases",
      "source": 97,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Systemic amyloidoses are characterized by the deposition of culprit proteins such as immunoglobulin light chains (intact or fragments) and many acute-phase proteins (SAA, transthyretin, fibrinogen α-chain, β2-macroglobulin, lysozyme, and gelsolin) [1, 21].",
      "key": "2022d5e81874959a1d1d62231900c2be",
      "line": 142,
      "relation": "increases",
      "source": 97,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Although intracellular β-fibrils may undergo autophagocytosis, they still display a clear insensitivity to the intralysosomal acidic proteases, leading to lipofuscin accumulation that can be observed in aged and amyloidosic tissues [46].",
      "key": "4966441296910a42dc4b8021a3498ddc",
      "line": 325,
      "relation": "increases",
      "source": 97,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Intracellular β-fibrils are able to activate various pathways of oxidative metabolism with production of ROS which contribute substantially to the cell damage.",
      "key": "83ddaffbdab33522f2ae79e811513dbe",
      "line": 103,
      "relation": "increases",
      "source": 55,
      "subject": {
        "location": {
          "name": "intracellular",
          "namespace": "GO"
        }
      },
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Intracellular β-fibrils are able to activate various pathways of oxidative metabolism with production of ROS which contribute substantially to the cell damage.",
      "key": "6d39fe9842c505c16b733a09864a5115",
      "line": 104,
      "relation": "increases",
      "source": 55,
      "subject": {
        "location": {
          "name": "intracellular",
          "namespace": "GO"
        }
      },
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Intracellular β-fibrils are able to activate various pathways of oxidative metabolism with production of ROS which contribute substantially to the cell damage.",
      "key": "2a29aa010b2bb6a3ac75d0dd8ced9182",
      "line": 105,
      "relation": "increases",
      "source": 55,
      "subject": {
        "location": {
          "name": "intracellular",
          "namespace": "GO"
        }
      },
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "291b0f8b99b7bdd1051944c7289fb0cb",
      "line": 235,
      "relation": "increases",
      "source": 55,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "β-Fibrils exhibit a green birefringence at polarized light under an optical microscope after red Congo staining and more importantly a strong resistance to proteases that normally provide to their turnover in order to avoid accumulation in cells and tissues [2].",
      "key": "031eb291d04184946dc9d7486d12ca4e",
      "line": 96,
      "relation": "decreases",
      "source": 82,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "β-Fibrils exhibit a green birefringence at polarized light under an optical microscope after red Congo staining and more importantly a strong resistance to proteases that normally provide to their turnover in order to avoid accumulation in cells and tissues [2].",
      "key": "754478983ef0e565d339dc15dea618bc",
      "line": 97,
      "relation": "increases",
      "source": 54,
      "target": 97
    },
    {
      "key": "21654affe0e88b80840dde1b3f08f2b2",
      "relation": "partOf",
      "source": 54,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, in this area, a hypoxic environment is generated, leading to HIF-1α activation that is accompanied by NFκB activation. Importantly, both HIF-1α and NFκB trigger and amplify the inflammatory reparative response and cellular damage [28].",
      "key": "81f2e2f5c757ada8f87add3ee46be13d",
      "line": 152,
      "relation": "increases",
      "source": 54,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, in this area, a hypoxic environment is generated, leading to HIF-1α activation that is accompanied by NFκB activation. Importantly, both HIF-1α and NFκB trigger and amplify the inflammatory reparative response and cellular damage [28].",
      "key": "d0563c2a12633e63b827093ea3d36821",
      "line": 154,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 54,
      "target": 80
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Although intracellular β-fibrils may undergo autophagocytosis, they still display a clear insensitivity to the intralysosomal acidic proteases, leading to lipofuscin accumulation that can be observed in aged and amyloidosic tissues [46].",
      "key": "ed6c3165ab3439c86205d4802ec00d36",
      "line": 323,
      "relation": "increases",
      "source": 54,
      "subject": {
        "location": {
          "name": "intracellular",
          "namespace": "GO"
        }
      },
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Although intracellular β-fibrils may undergo autophagocytosis, they still display a clear insensitivity to the intralysosomal acidic proteases, leading to lipofuscin accumulation that can be observed in aged and amyloidosic tissues [46].",
      "key": "dcc267a0f893dd29d5c63f9d1c46d952",
      "line": 324,
      "relation": "increases",
      "source": 54,
      "subject": {
        "location": {
          "name": "intracellular",
          "namespace": "GO"
        }
      },
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "In conclusion, as it has been underlined previously, progressive accumulation of amyloid fibrils is responsible for a local hypoxia and of a chronic long lasting inflammation, which in turn produces tissue damage leading to continuous repair, fibrosis, and organ insufficiency.",
      "key": "5638c4641ba64fd7a67430eaa2289484",
      "line": 336,
      "relation": "increases",
      "source": 54,
      "target": 99
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "In conclusion, as it has been underlined previously, progressive accumulation of amyloid fibrils is responsible for a local hypoxia and of a chronic long lasting inflammation, which in turn produces tissue damage leading to continuous repair, fibrosis, and organ insufficiency.",
      "key": "99251d361fd430505cb2c5ead1a22bd8",
      "line": 337,
      "relation": "increases",
      "source": 54,
      "target": 102
    },
    {
      "key": "df97ea0185672dbf4c1f180f744d913a",
      "relation": "partOf",
      "source": 58,
      "target": 55
    },
    {
      "key": "ae5d56684dd94ebd6bd1ccfe1858b752",
      "relation": "partOf",
      "source": 79,
      "target": 55
    },
    {
      "key": "c73caff996c01944081c6cc21cc01d57",
      "relation": "partOf",
      "source": 79,
      "target": 46
    },
    {
      "key": "2837a2e326ed80ccf91f12be6fd0731f",
      "relation": "partOf",
      "source": 59,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Recently, it has been shown [50] that recombinant APC (activated protein C, a plasma protease) or its analogs, inhibiting the neuronal β-secretase, may strongly slow or block the generation of β-amyloid protein protecting from Alzheimer’s disease or slowing its progression [51, 52]",
      "key": "133443cb7a00a1e8f11cb29778a027c6",
      "line": 351,
      "relation": "increases",
      "source": 59,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This interaction may protect β-aggregates from proteolysis on one side and stimulate their phagocytosis by macrophages on the other side (Figure 1) [19, 20].",
      "key": "4823c24798c05690f372de816d0ab2d1",
      "line": 123,
      "relation": "decreases",
      "source": 46,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This interaction may protect β-aggregates from proteolysis on one side and stimulate their phagocytosis by macrophages on the other side (Figure 1) [19, 20].",
      "key": "d3e060e127f8123af682c283451791cb",
      "line": 124,
      "relation": "increases",
      "source": 46,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This interaction may protect β-aggregates from proteolysis on one side and stimulate their phagocytosis by macrophages on the other side (Figure 1) [19, 20].",
      "key": "9bc66b869873bd47a3ac64ca04d3d372",
      "line": 125,
      "relation": "increases",
      "source": 29,
      "target": 36
    },
    {
      "key": "d6c52dfe23aac7be6505d2f079b8e106",
      "relation": "hasVariant",
      "source": 92,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, in this area, a hypoxic environment is generated, leading to HIF-1α activation that is accompanied by NFκB activation. Importantly, both HIF-1α and NFκB trigger and amplify the inflammatory reparative response and cellular damage [28].",
      "key": "9614a285cf317f2df4cbd6eca7902c6b",
      "line": 153,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 38,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, in this area, a hypoxic environment is generated, leading to HIF-1α activation that is accompanied by NFκB activation. Importantly, both HIF-1α and NFκB trigger and amplify the inflammatory reparative response and cellular damage [28].",
      "key": "a8f915a361f9598dbd6bf811c2ffbcf6",
      "line": 155,
      "relation": "increases",
      "source": 65,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "2911efe7550c6db2434ba573b868da0f",
      "line": 217,
      "relation": "increases",
      "source": 65,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, in this area, a hypoxic environment is generated, leading to HIF-1α activation that is accompanied by NFκB activation. Importantly, both HIF-1α and NFκB trigger and amplify the inflammatory reparative response and cellular damage [28].",
      "key": "2004897a95423231c27a501f78dd71da",
      "line": 156,
      "relation": "increases",
      "source": 65,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "2afbc51c10d0ae7fb64df3e846988603",
      "line": 202,
      "relation": "increases",
      "source": 65,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "f24f03a3352a91c98e07c0b806a18482",
      "line": 204,
      "relation": "increases",
      "source": 65,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "09d11a4b819f293e50c11acff7a1cb9a",
      "line": 205,
      "relation": "increases",
      "source": 65,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "7251318275e30d3789ebc3d767368ecb",
      "line": 206,
      "relation": "increases",
      "source": 65,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "2c0670dd268d440fd12c05761d0f39c8",
      "line": 209,
      "relation": "increases",
      "source": 65,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "ba23ea9f86f74eee2cd7af7f97ad10c1",
      "line": 210,
      "relation": "increases",
      "source": 65,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "f8b6fd68bfefa8e678225b8cc4af986c",
      "line": 211,
      "relation": "increases",
      "source": 65,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "d791b04518b5b79908f37396661d0d17",
      "line": 212,
      "relation": "increases",
      "source": 65,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "48ca361a8c22e98be7634dc47724c878",
      "line": 213,
      "relation": "increases",
      "source": 65,
      "target": 85
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "2466baacbe54bf26850b3af26be1a537",
      "line": 218,
      "relation": "increases",
      "source": 65,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "6c2966926713f8fab74c563db081a7ce",
      "line": 219,
      "relation": "increases",
      "source": 65,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "40b46914948dd9b0255bb1ecd0a37f56",
      "line": 220,
      "relation": "increases",
      "source": 65,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "4193a10abd5d320db7d77a82582aefb3",
      "line": 221,
      "relation": "increases",
      "source": 65,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, in this area, a hypoxic environment is generated, leading to HIF-1α activation that is accompanied by NFκB activation. Importantly, both HIF-1α and NFκB trigger and amplify the inflammatory reparative response and cellular damage [28].",
      "key": "f53f06548a463614a4e55de6e4c7d0ba",
      "line": 157,
      "relation": "increases",
      "source": 80,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Through these mechanisms, inflammation and ROS contribute substantially to the cell/ tissue damage and severity of the disease.",
      "key": "ba8116cd1b46dec636802f7feee1fa2d",
      "line": 306,
      "relation": "increases",
      "source": 80,
      "subject": {
        "modifier": "Activity"
      },
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, in this area, a hypoxic environment is generated, leading to HIF-1α activation that is accompanied by NFκB activation. Importantly, both HIF-1α and NFκB trigger and amplify the inflammatory reparative response and cellular damage [28].",
      "key": "b4aaab8cadf6c16119afce44645b9b12",
      "line": 158,
      "relation": "increases",
      "source": 80,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Extracellular β-fibril-alarmin receptor binding can then activate NFκB pathways for oxidative metabolism and apoptosis [40, 41] as well as phagocytic activity of macrophages (Figure 1(c)).",
      "key": "8614423168f2fe8484f95b49647c8fe4",
      "line": 286,
      "relation": "increases",
      "source": 80,
      "subject": {
        "modifier": "Activity"
      },
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Extracellular β-fibril-alarmin receptor binding can then activate NFκB pathways for oxidative metabolism and apoptosis [40, 41] as well as phagocytic activity of macrophages (Figure 1(c)).",
      "key": "e63c05452000154263ea7711fb437773",
      "line": 287,
      "relation": "increases",
      "source": 80,
      "subject": {
        "modifier": "Activity"
      },
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Extracellular β-fibril-alarmin receptor binding can then activate NFκB pathways for oxidative metabolism and apoptosis [40, 41] as well as phagocytic activity of macrophages (Figure 1(c)).",
      "key": "32ddd86e4b5981cddadc8486085ec3f7",
      "line": 288,
      "relation": "increases",
      "source": 80,
      "subject": {
        "modifier": "Activity"
      },
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Through these mechanisms, inflammation and ROS contribute substantially to the cell/ tissue damage and severity of the disease.",
      "key": "f9ddffb83b9647d954ded1fc5099b334",
      "line": 308,
      "relation": "increases",
      "source": 80,
      "subject": {
        "modifier": "Activity"
      },
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Through these mechanisms, inflammation and ROS contribute substantially to the cell/ tissue damage and severity of the disease.",
      "key": "98844e231a53efeed5beb4343006450a",
      "line": 310,
      "relation": "increases",
      "source": 28,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Through these mechanisms, inflammation and ROS contribute substantially to the cell/ tissue damage and severity of the disease.",
      "key": "921c09924f140dadadbf77c5f0439d8e",
      "line": 311,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 28,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "O2 shortage causes inhibition of ATP production, rapid fall of the energy charge, and loss of ionic gradients with the alteration of cytosolic calcium homeostasis [29].",
      "key": "49a0a8b20e4530179c2396a566b7f3b8",
      "line": 166,
      "relation": "increases",
      "source": 6,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "O2 shortage causes inhibition of ATP production, rapid fall of the energy charge, and loss of ionic gradients with the alteration of cytosolic calcium homeostasis [29].",
      "key": "4f833a41bea95649ce9e5b6d50527db2",
      "line": 167,
      "relation": "increases",
      "source": 6,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "O2 shortage causes inhibition of ATP production, rapid fall of the energy charge, and loss of ionic gradients with the alteration of cytosolic calcium homeostasis [29].",
      "key": "b8d5bc9e977a0341bc30cbc05fffbc57",
      "line": 168,
      "relation": "increases",
      "source": 6,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "O2 shortage causes inhibition of ATP production, rapid fall of the energy charge, and loss of ionic gradients with the alteration of cytosolic calcium homeostasis [29].",
      "key": "181dce45cad421b37e28ff4a1d4abe55",
      "line": 169,
      "relation": "regulates",
      "source": 6,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The increase of cytosolic Ca++ concentration above 10-6 M dramatically activates the peroxidative metabolism, an irreversible contraction and degradation of the cytoskeleton and the activation of Ca++-dependent cytosolic proteases (calpains) and DNAases, leading to an irreversible and rapid cell degradation [30].",
      "key": "12aa4226d6a78f3c111dfe4f65809686",
      "line": 180,
      "relation": "increases",
      "source": 1,
      "subject": {
        "location": {
          "name": "Cytosol",
          "namespace": "MESH"
        }
      },
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The increase of cytosolic Ca++ concentration above 10-6 M dramatically activates the peroxidative metabolism, an irreversible contraction and degradation of the cytoskeleton and the activation of Ca++-dependent cytosolic proteases (calpains) and DNAases, leading to an irreversible and rapid cell degradation [30].",
      "key": "a18f4d97a0d9ce534d74ca473c307281",
      "line": 182,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 1,
      "subject": {
        "location": {
          "name": "Cytosol",
          "namespace": "MESH"
        }
      },
      "target": 83
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The increase of cytosolic Ca++ concentration above 10-6 M dramatically activates the peroxidative metabolism, an irreversible contraction and degradation of the cytoskeleton and the activation of Ca++-dependent cytosolic proteases (calpains) and DNAases, leading to an irreversible and rapid cell degradation [30].",
      "key": "4ffa6b8b8d8e0d0d33e1cf76d7b0809a",
      "line": 183,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 1,
      "subject": {
        "location": {
          "name": "Cytosol",
          "namespace": "MESH"
        }
      },
      "target": 87
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The increase of cytosolic Ca++ concentration above 10-6 M dramatically activates the peroxidative metabolism, an irreversible contraction and degradation of the cytoskeleton and the activation of Ca++-dependent cytosolic proteases (calpains) and DNAases, leading to an irreversible and rapid cell degradation [30].",
      "key": "91ee1336415de606d828fa07ff768dc4",
      "line": 181,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 30,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The increase of cytosolic Ca++ concentration above 10-6 M dramatically activates the peroxidative metabolism, an irreversible contraction and degradation of the cytoskeleton and the activation of Ca++-dependent cytosolic proteases (calpains) and DNAases, leading to an irreversible and rapid cell degradation [30].",
      "key": "006a35d3203ddbdef057d01889a574b4",
      "line": 184,
      "relation": "increases",
      "source": 83,
      "subject": {
        "modifier": "Activity"
      },
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The increase of cytosolic Ca++ concentration above 10-6 M dramatically activates the peroxidative metabolism, an irreversible contraction and degradation of the cytoskeleton and the activation of Ca++-dependent cytosolic proteases (calpains) and DNAases, leading to an irreversible and rapid cell degradation [30].",
      "key": "7715e0af8c053313dbe80eefb1a08fc4",
      "line": 185,
      "relation": "increases",
      "source": 87,
      "subject": {
        "modifier": "Activity"
      },
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "14ff265418013f74e07326f238b4965c",
      "line": 203,
      "relation": "increases",
      "source": 51,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "54ae26e42a4bbb72f959f649bb7adec7",
      "line": 207,
      "relation": "increases",
      "source": 76,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "0cd787f1006f5f6ba86fc53a645498c0",
      "line": 208,
      "relation": "increases",
      "source": 66,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "c9cae336ec15990041a59c14023b2386",
      "line": 214,
      "relation": "increases",
      "source": 12,
      "target": 28
    },
    {
      "key": "b5d1782dc85e7a05787f8cc1976f841e",
      "relation": "partOf",
      "source": 12,
      "target": 43
    },
    {
      "key": "05d9a7c3d3bb885ff980c6326a98207d",
      "relation": "partOf",
      "source": 12,
      "target": 44
    },
    {
      "key": "d6abe018dd2af2dfc4feaf9d32b3fbb0",
      "relation": "partOf",
      "source": 12,
      "target": 45
    },
    {
      "key": "b7801b645696889e8565454f3bba0c6c",
      "relation": "partOf",
      "source": 12,
      "target": 42
    },
    {
      "key": "5800c902f0a5a55818e3fd90e8bc8763",
      "relation": "partOf",
      "source": 12,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "0fe5910bd7941f90327bd04724682f3d",
      "line": 215,
      "relation": "increases",
      "source": 13,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "This adaptation to hypoxia occurs through the activation of hypoxic inducible factors (HIFs) [32] and the expression of a number of HIF-1α- dependent genes, involved in vital pathways, such as angiogenesis (vascular endothelial growth factors or VEGFs), metabolism (glucose transporter 1 or Glut1, hexokinase II or HKII, and glycolysis) [33], inflammation (Toll-like receptors or TLRs and other receptors for alarmins, cytokines, and matrix metalloproteinases or MMPs), and repair (autophagocytosis for disposal of damaged cell components, telomerase reverse transcriptase (TERT), and stemness genes to increase the stem cell compartment to substitute death cells) [34], transforming growth factor β (TGF-β) and fibrosis pathways [33].",
      "key": "6d9a834e046fa21c144dec389ddd7564",
      "line": 216,
      "relation": "increases",
      "source": 85,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "f75f5a7fe0e6aeaf2bb335cb3bff4d5c",
      "line": 234,
      "relation": "increases",
      "source": 31,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "0e91ec1044fc17fce75b35d09ab5f0cf",
      "line": 236,
      "relation": "increases",
      "source": 67,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "586714f56999fae49c557d5e08b69c97",
      "line": 237,
      "relation": "increases",
      "source": 20,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "666db146b5fa5219cbe2d75ce2759f79",
      "line": 238,
      "relation": "increases",
      "source": 94,
      "target": 12
    },
    {
      "annotations": {
        "Anatomy": {
          "parenchyma": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "c48e7d4836d00e37fee364e32071acb1",
      "line": 240,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 43,
      "target": 80
    },
    {
      "annotations": {
        "Anatomy": {
          "parenchyma": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "c00819958135df9ba34584888b3bc34a",
      "line": 241,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 43,
      "target": 77
    },
    {
      "annotations": {
        "Anatomy": {
          "parenchyma": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "d8248135d329fc8cfe4dcc7fbfe97da3",
      "line": 242,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 43,
      "target": 40
    },
    {
      "key": "294cb08374c7a201158621b041ebd64f",
      "relation": "partOf",
      "source": 57,
      "target": 43
    },
    {
      "annotations": {
        "Anatomy": {
          "parenchyma": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "f9d47c4e2737f0d34b2b64fecf57b987",
      "line": 243,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 44,
      "target": 80
    },
    {
      "annotations": {
        "Anatomy": {
          "parenchyma": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "716be0d6fed186da721134bb13636c82",
      "line": 244,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 44,
      "target": 77
    },
    {
      "annotations": {
        "Anatomy": {
          "parenchyma": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "26278dd19e7561b35b9e69b0abf6eb3f",
      "line": 245,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 44,
      "target": 40
    },
    {
      "key": "0e74ebe0f812078294915465e9b72db8",
      "relation": "partOf",
      "source": 71,
      "target": 44
    },
    {
      "annotations": {
        "Anatomy": {
          "parenchyma": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "1abe342f9688fa834270a91a6d761d7c",
      "line": 246,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 45,
      "target": 80
    },
    {
      "annotations": {
        "Anatomy": {
          "parenchyma": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "7248df8eb79ad351426ade35850c4041",
      "line": 247,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 45,
      "target": 77
    },
    {
      "annotations": {
        "Anatomy": {
          "parenchyma": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "d07373613bd08467fa890fac9228a9fe",
      "line": 248,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 45,
      "target": 40
    },
    {
      "key": "edf68727e9368508f560bb846d3ebe3c",
      "relation": "partOf",
      "source": 81,
      "target": 45
    },
    {
      "annotations": {
        "Anatomy": {
          "parenchyma": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "08b596ff36d2a3aa68b9ef37f364ae8d",
      "line": 249,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 42,
      "target": 80
    },
    {
      "annotations": {
        "Anatomy": {
          "parenchyma": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "9dc913ef218eb31093ef5c9743f6133b",
      "line": 250,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 42,
      "target": 77
    },
    {
      "annotations": {
        "Anatomy": {
          "parenchyma": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, alarmins released by necrotic cells (β-fibrils, high-mobility group box 1 or HMGB1, ATP/ADP, membrane debris, nucleic acids, etc.) bind to these newly expressed receptors producing an additional activation of transcription factors (NFκB, STAT3, AP1, etc.) driving IRR gene transcription not only in resident inflammatory cells but also in remodeled parenchymal cells [26, 27].",
      "key": "c4b954681ad91bc2b490a9adccc597c9",
      "line": 251,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 42,
      "target": 40
    },
    {
      "key": "eed9941f3470ace57caeb5dc7a789a0c",
      "relation": "partOf",
      "source": 39,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Through these mechanisms, inflammation and ROS contribute substantially to the cell/ tissue damage and severity of the disease.",
      "key": "64a83597cdd5ed90a3d363579e1547d2",
      "line": 307,
      "relation": "increases",
      "source": 39,
      "subject": {
        "modifier": "Activity"
      },
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Through these mechanisms, inflammation and ROS contribute substantially to the cell/ tissue damage and severity of the disease.",
      "key": "f06f574b9a9f7ea647d004cf7eb3d7c5",
      "line": 309,
      "relation": "increases",
      "source": 39,
      "subject": {
        "modifier": "Activity"
      },
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The utilization of NFκB inhibitors, anti-inflammatory drugs, and anti-inflammasome agents is aimed at modulating and inhibiting chronic inflammation and ROS production responsible for continuous cell damage, repair, and fibrosis [31, 60]",
      "key": "3be7b45a1084ced9902332ce72f726d6",
      "line": 406,
      "relation": "positiveCorrelation",
      "source": 39,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The utilization of NFκB inhibitors, anti-inflammatory drugs, and anti-inflammasome agents is aimed at modulating and inhibiting chronic inflammation and ROS production responsible for continuous cell damage, repair, and fibrosis [31, 60]",
      "key": "be105d8a070d78fd4a1d9eedb1a7bd92",
      "line": 405,
      "relation": "positiveCorrelation",
      "source": 39,
      "target": 102
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The latter further activate oxidative metabolism, produce mediators and other proinflammatory cytokines, and maintain a chronic inflammatory status in the affected tissue.",
      "key": "6d9eda8c50f56c840b64853adde29a32",
      "line": 261,
      "relation": "increases",
      "source": 69,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The latter further activate oxidative metabolism, produce mediators and other proinflammatory cytokines, and maintain a chronic inflammatory status in the affected tissue.",
      "key": "55b231d91ce741cb6e63f7276f1223d7",
      "line": 262,
      "relation": "increases",
      "source": 69,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The latter further activate oxidative metabolism, produce mediators and other proinflammatory cytokines, and maintain a chronic inflammatory status in the affected tissue.",
      "key": "1884853ef9bfffb8318de92f3cc2705c",
      "line": 263,
      "relation": "increases",
      "source": 69,
      "target": 101
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Unfortunately, clinical consequences of this prolonged IRR activation include cell/tissue damage, continuous repair and fibrosis with progressive deterioration of the function leading to organ insufficiency, and neuronal damages, the typical final outcome of amyloidoses [5, 7, 36].",
      "key": "86bf5ae89399b346066c12824909f47b",
      "line": 273,
      "relation": "increases",
      "source": 69,
      "subject": {
        "modifier": "Activity"
      },
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Unfortunately, clinical consequences of this prolonged IRR activation include cell/tissue damage, continuous repair and fibrosis with progressive deterioration of the function leading to organ insufficiency, and neuronal damages, the typical final outcome of amyloidoses [5, 7, 36].",
      "key": "3872157a27822cfb2933250c9c29c405",
      "line": 274,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 69,
      "subject": {
        "modifier": "Activity"
      },
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Unfortunately, clinical consequences of this prolonged IRR activation include cell/tissue damage, continuous repair and fibrosis with progressive deterioration of the function leading to organ insufficiency, and neuronal damages, the typical final outcome of amyloidoses [5, 7, 36].",
      "key": "2e3d39d6b01876cf354239dc1ce07f0a",
      "line": 275,
      "relation": "increases",
      "source": 69,
      "subject": {
        "modifier": "Activity"
      },
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Unfortunately, clinical consequences of this prolonged IRR activation include cell/tissue damage, continuous repair and fibrosis with progressive deterioration of the function leading to organ insufficiency, and neuronal damages, the typical final outcome of amyloidoses [5, 7, 36].",
      "key": "b2d4b2d6420fa56be17eb934ff8800f5",
      "line": 276,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 69,
      "subject": {
        "modifier": "Activity"
      },
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Unfortunately, clinical consequences of this prolonged IRR activation include cell/tissue damage, continuous repair and fibrosis with progressive deterioration of the function leading to organ insufficiency, and neuronal damages, the typical final outcome of amyloidoses [5, 7, 36].",
      "key": "67e0ae1240c40fb32777c26c516af576",
      "line": 277,
      "relation": "increases",
      "source": 69,
      "subject": {
        "modifier": "Activity"
      },
      "target": 97
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "In conclusion, as it has been underlined previously, progressive accumulation of amyloid fibrils is responsible for a local hypoxia and of a chronic long lasting inflammation, which in turn produces tissue damage leading to continuous repair, fibrosis, and organ insufficiency.",
      "key": "4d07459f1ebffeffb9c065ab77586730",
      "line": 339,
      "relation": "increases",
      "source": 17,
      "subject": {
        "modifier": "Degradation"
      },
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Extracellular β-fibril-alarmin receptor binding can then activate NFκB pathways for oxidative metabolism and apoptosis [40, 41] as well as phagocytic activity of macrophages (Figure 1(c)).",
      "key": "de30e31ab70357be0bffcb152f2ca169",
      "line": 285,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 41,
      "subject": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        }
      },
      "target": 80
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Extracellular β-fibril-alarmin receptor binding can then activate NFκB pathways for oxidative metabolism and apoptosis [40, 41] as well as phagocytic activity of macrophages (Figure 1(c)).",
      "key": "3d7cc3c79af9f5a70cc5d4751039acf8",
      "line": 289,
      "relation": "increases",
      "source": 41,
      "subject": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        }
      },
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Extracellular β-fibril-alarmin receptor binding can then activate NFκB pathways for oxidative metabolism and apoptosis [40, 41] as well as phagocytic activity of macrophages (Figure 1(c)).",
      "key": "da2a6bfd731570c43d3af932c347b9f0",
      "line": 290,
      "relation": "increases",
      "source": 41,
      "subject": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        }
      },
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Extracellular β-fibril-alarmin receptor binding can then activate NFκB pathways for oxidative metabolism and apoptosis [40, 41] as well as phagocytic activity of macrophages (Figure 1(c)).",
      "key": "9c2a0f89ac85354225b69183ffa53e23",
      "line": 291,
      "relation": "increases",
      "source": 41,
      "subject": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        }
      },
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "On the other hand, intracellular β-fibrils are able to activate inflammasomes [42, 43].",
      "key": "be17cd213cf6a3d15e63096613245903",
      "line": 298,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 41,
      "subject": {
        "location": {
          "name": "intracellular",
          "namespace": "GO"
        }
      },
      "target": 39
    },
    {
      "key": "7355c63b9dbd82c1bcc8db52ce57f703",
      "relation": "partOf",
      "source": 10,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Through these mechanisms, inflammation and ROS contribute substantially to the cell/ tissue damage and severity of the disease.",
      "key": "d77aa0a32f6ee4c50e9d126e1530462a",
      "line": 312,
      "relation": "increases",
      "source": 2,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Through these mechanisms, inflammation and ROS contribute substantially to the cell/ tissue damage and severity of the disease.",
      "key": "ecf8dfed68a58ec86ad0489abf6a6184",
      "line": 313,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 2,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The utilization of NFκB inhibitors, anti-inflammatory drugs, and anti-inflammasome agents is aimed at modulating and inhibiting chronic inflammation and ROS production responsible for continuous cell damage, repair, and fibrosis [31, 60]",
      "key": "987f94c9021079ee85a0f5d59414c6db",
      "line": 404,
      "relation": "negativeCorrelation",
      "source": 2,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The utilization of NFκB inhibitors, anti-inflammatory drugs, and anti-inflammasome agents is aimed at modulating and inhibiting chronic inflammation and ROS production responsible for continuous cell damage, repair, and fibrosis [31, 60]",
      "key": "91a80d5e944bf727a3712e35990682c2",
      "line": 406,
      "relation": "positiveCorrelation",
      "source": 2,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "In conclusion, as it has been underlined previously, progressive accumulation of amyloid fibrils is responsible for a local hypoxia and of a chronic long lasting inflammation, which in turn produces tissue damage leading to continuous repair, fibrosis, and organ insufficiency.",
      "key": "a1fa40325fd4be969254ef732319566a",
      "line": 338,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 102,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The utilization of NFκB inhibitors, anti-inflammatory drugs, and anti-inflammasome agents is aimed at modulating and inhibiting chronic inflammation and ROS production responsible for continuous cell damage, repair, and fibrosis [31, 60]",
      "key": "757df410d244386bc293bd3d41af870f",
      "line": 403,
      "relation": "negativeCorrelation",
      "source": 102,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The utilization of NFκB inhibitors, anti-inflammatory drugs, and anti-inflammasome agents is aimed at modulating and inhibiting chronic inflammation and ROS production responsible for continuous cell damage, repair, and fibrosis [31, 60]",
      "key": "7dcc69bf3e1ba9790c036abb7d944cdc",
      "line": 405,
      "relation": "positiveCorrelation",
      "source": 102,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Recently, it has been shown [50] that recombinant APC (activated protein C, a plasma protease) or its analogs, inhibiting the neuronal β-secretase, may strongly slow or block the generation of β-amyloid protein protecting from Alzheimer’s disease or slowing its progression [51, 52]",
      "key": "939838d326d14fbba99f2e13781ecb1e",
      "line": 349,
      "object": {
        "location": {
          "name": "neuron part",
          "namespace": "GO"
        }
      },
      "relation": "decreases",
      "source": 73,
      "subject": {
        "modifier": "Activity"
      },
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Recently, it has been shown [50] that recombinant APC (activated protein C, a plasma protease) or its analogs, inhibiting the neuronal β-secretase, may strongly slow or block the generation of β-amyloid protein protecting from Alzheimer’s disease or slowing its progression [51, 52]",
      "key": "b8bb0595f741f321b1ed690d6ae34f05",
      "line": 350,
      "relation": "decreases",
      "source": 73,
      "subject": {
        "modifier": "Activity"
      },
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Recently, it has been shown [50] that recombinant APC (activated protein C, a plasma protease) or its analogs, inhibiting the neuronal β-secretase, may strongly slow or block the generation of β-amyloid protein protecting from Alzheimer’s disease or slowing its progression [51, 52]",
      "key": "898df056af2ac7450fc9fbdcce63436e",
      "line": 352,
      "relation": "decreases",
      "source": 73,
      "subject": {
        "modifier": "Activity"
      },
      "target": 96
    },
    {
      "key": "934bd781ee4bfdbbf5a2da17b5155fd9",
      "relation": "hasVariant",
      "source": 72,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Using chaperones [53, 54], small molecules [54], and aspirin [55] slows or inhibits polymer formation [50, 55, 56] and β-fibril aggregation and accumulation, preventing the disease and attenuating its progression and symptoms.",
      "key": "b025dcbce3e81d4dfac9043e7e40d543",
      "line": 361,
      "relation": "decreases",
      "source": 95,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Using chaperones [53, 54], small molecules [54], and aspirin [55] slows or inhibits polymer formation [50, 55, 56] and β-fibril aggregation and accumulation, preventing the disease and attenuating its progression and symptoms.",
      "key": "9dbb49e538a8ee60af2ed18d8b2841b0",
      "line": 363,
      "relation": "decreases",
      "source": 95,
      "target": 54
    },
    {
      "key": "d7e979ba60993046491468eaac23add7",
      "relation": "hasVariant",
      "source": 88,
      "target": 90
    },
    {
      "key": "7a4f2410b5f4c49e975c47c11f2473b5",
      "relation": "hasVariant",
      "source": 88,
      "target": 89
    },
    {
      "key": "1df5d250ca9ad14464b5c0d2e289adf5",
      "relation": "hasVariant",
      "source": 88,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Using chaperones [53, 54], small molecules [54], and aspirin [55] slows or inhibits polymer formation [50, 55, 56] and β-fibril aggregation and accumulation, preventing the disease and attenuating its progression and symptoms.",
      "key": "404583617a0064410d5a9afdb1ace345",
      "line": 362,
      "relation": "decreases",
      "source": 0,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Using chaperones [53, 54], small molecules [54], and aspirin [55] slows or inhibits polymer formation [50, 55, 56] and β-fibril aggregation and accumulation, preventing the disease and attenuating its progression and symptoms.",
      "key": "b85d7b79ec50063e7184b2186faacade",
      "line": 364,
      "relation": "decreases",
      "source": 0,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Although the mechanism(s) is still unclear, it has been demonstrated that aspirin is able to donate its acetyl group to the culprit proteins, increasing their acetylation and reducing the tendency of phosphorylation.",
      "key": "3080b6255f1830d442581fe467b1b9d5",
      "line": 372,
      "relation": "increases",
      "source": 0,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Although the mechanism(s) is still unclear, it has been demonstrated that aspirin is able to donate its acetyl group to the culprit proteins, increasing their acetylation and reducing the tendency of phosphorylation.",
      "key": "e54157effde77315c2b89d5a4ffc00b5",
      "line": 374,
      "relation": "decreases",
      "source": 0,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Aspirin may, as well, contribute with other beneficial mechanisms, such as inhibition of NFκB and cyclooxygenase, reducing the damaging impact of the inflammatory reparative response.",
      "key": "7b4836c992ce98361aa7d953d95fc179",
      "line": 382,
      "relation": "decreases",
      "source": 0,
      "target": 80
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Aspirin may, as well, contribute with other beneficial mechanisms, such as inhibition of NFκB and cyclooxygenase, reducing the damaging impact of the inflammatory reparative response.",
      "key": "bd1dd7769c0f067992117aa9cb280e12",
      "line": 383,
      "relation": "decreases",
      "source": 0,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Although the mechanism(s) is still unclear, it has been demonstrated that aspirin is able to donate its acetyl group to the culprit proteins, increasing their acetylation and reducing the tendency of phosphorylation.",
      "key": "1262682979a679b52c0b96d9d9ea66a3",
      "line": 373,
      "relation": "decreases",
      "source": 89,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "A long list of potential HIF-1α inhibitors is now available, such as digoxin, acriflavine, doxorubicin, and chetomin [57–59]",
      "key": "8bcc1139321dccaf9cd64f98dba159d7",
      "line": 391,
      "relation": "decreases",
      "source": 5,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "A long list of potential HIF-1α inhibitors is now available, such as digoxin, acriflavine, doxorubicin, and chetomin [57–59]",
      "key": "30b3cb66c9b3fef75ae3c816c2a8bce0",
      "line": 392,
      "relation": "decreases",
      "source": 18,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "A long list of potential HIF-1α inhibitors is now available, such as digoxin, acriflavine, doxorubicin, and chetomin [57–59]",
      "key": "11e765c7e757607fc2bc7b791034ed2e",
      "line": 393,
      "relation": "decreases",
      "source": 7,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "A long list of potential HIF-1α inhibitors is now available, such as digoxin, acriflavine, doxorubicin, and chetomin [57–59]",
      "key": "370c92af337ad0f6a49dfb84521b6d3a",
      "line": 394,
      "relation": "decreases",
      "source": 3,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The utilization of NFκB inhibitors, anti-inflammatory drugs, and anti-inflammasome agents is aimed at modulating and inhibiting chronic inflammation and ROS production responsible for continuous cell damage, repair, and fibrosis [31, 60]",
      "key": "61fa16fc3bfd3eefb89dbe98613cd04d",
      "line": 403,
      "relation": "negativeCorrelation",
      "source": 11,
      "target": 102
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "The utilization of NFκB inhibitors, anti-inflammatory drugs, and anti-inflammasome agents is aimed at modulating and inhibiting chronic inflammation and ROS production responsible for continuous cell damage, repair, and fibrosis [31, 60]",
      "key": "006a89a0e7e904ac85c7f0b2a5ffdb3f",
      "line": 404,
      "relation": "negativeCorrelation",
      "source": 11,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, natural nutrients [64] such as curcumin and in particular vanillin, a degradation product of curcumin, have been shown to reduce the formation of advanced glycation end products (AGEs) [65].",
      "key": "7d5404aa69c33b2d2543698cf63f120b",
      "line": 415,
      "relation": "decreases",
      "source": 4,
      "target": 84
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, natural nutrients [64] such as curcumin and in particular vanillin, a degradation product of curcumin, have been shown to reduce the formation of advanced glycation end products (AGEs) [65].",
      "key": "ead92b17304ed28eac6b5a535c473128",
      "line": 416,
      "relation": "increases",
      "source": 4,
      "subject": {
        "modifier": "Degradation"
      },
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "As a consequence, natural nutrients [64] such as curcumin and in particular vanillin, a degradation product of curcumin, have been shown to reduce the formation of advanced glycation end products (AGEs) [65].",
      "key": "9abd37534a4e1eac206d0d0dd7f06acb",
      "line": 417,
      "relation": "decreases",
      "source": 9,
      "target": 84
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "Recently, physical exercise has been shown to be able to prevent Alzheimer’s disease and substantially slow its progression.",
      "key": "49f0189b5d94b0ddf3aaa300f0ccace0",
      "line": 424,
      "relation": "decreases",
      "source": 98,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "In particular, the release of survival factors, such as BDGF (neurons), IGF-1 (systemic or organ-specific release), and testosterone, and the activation of survival/repairing pathways, such as sirtuin-dependent transcription factors, are able to reduce apoptosis and to repair abnormal cell components, rescuing sublethally damaged postmitotic cells, such as neurons [66], myocardiocytes, skeletal muscle, and hepatocytes [67].",
      "key": "cb622a84144f66f05c47496891089ec4",
      "line": 436,
      "relation": "decreases",
      "source": 62,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "In particular, the release of survival factors, such as BDGF (neurons), IGF-1 (systemic or organ-specific release), and testosterone, and the activation of survival/repairing pathways, such as sirtuin-dependent transcription factors, are able to reduce apoptosis and to repair abnormal cell components, rescuing sublethally damaged postmitotic cells, such as neurons [66], myocardiocytes, skeletal muscle, and hepatocytes [67].",
      "key": "7d97e1852f5a2e830714fbfd68d7735a",
      "line": 437,
      "relation": "decreases",
      "source": 68,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "In particular, the release of survival factors, such as BDGF (neurons), IGF-1 (systemic or organ-specific release), and testosterone, and the activation of survival/repairing pathways, such as sirtuin-dependent transcription factors, are able to reduce apoptosis and to repair abnormal cell components, rescuing sublethally damaged postmitotic cells, such as neurons [66], myocardiocytes, skeletal muscle, and hepatocytes [67].",
      "key": "e2bbba27b4c9c8c3504e3b9dbaace83b",
      "line": 438,
      "relation": "decreases",
      "source": 8,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Frustaci A",
          "Limana F",
          "Russo MA",
          "Sansone L",
          "Tafani M",
          "Tomino C",
          "Vernucci E"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "31346362",
        "db_name": "Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets.",
        "first": "Russo MA",
        "journal": "Oxidative medicine and cellular longevity",
        "last": "Tafani M",
        "pages": "7935310",
        "volume": "2019"
      },
      "evidence": "In particular, the release of survival factors, such as BDGF (neurons), IGF-1 (systemic or organ-specific release), and testosterone, and the activation of survival/repairing pathways, such as sirtuin-dependent transcription factors, are able to reduce apoptosis and to repair abnormal cell components, rescuing sublethally damaged postmitotic cells, such as neurons [66], myocardiocytes, skeletal muscle, and hepatocytes [67].",
      "key": "3943e12eea233fe7bc99fd40ece75758",
      "line": 439,
      "relation": "decreases",
      "source": 75,
      "subject": {
        "modifier": "Activity"
      },
      "target": 32
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"acetylsalicylic acid\")",
      "concept": {
        "name": "acetylsalicylic acid",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "f82fe428cdfb5a5690423ad24932ad48"
    },
    {
      "bel": "a(CHEBI:\"calcium(2+)\")",
      "concept": {
        "name": "calcium(2+)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "94df77a2db8d9014b42535235da90e5d"
    },
    {
      "bel": "a(CHEBI:\"reactive oxygen species\")",
      "concept": {
        "name": "reactive oxygen species",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "39a67bec2ea8cb7a2bec39cf66e565ba"
    },
    {
      "bel": "a(CHEBI:chetomin)",
      "concept": {
        "name": "chetomin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "b289759aac56a67716d180d8bf13b4fb"
    },
    {
      "bel": "a(CHEBI:curcumin)",
      "concept": {
        "name": "curcumin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "7af57558091f98bed6718820d043f953"
    },
    {
      "bel": "a(CHEBI:digoxin)",
      "concept": {
        "name": "digoxin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "2e81538f1e7f54ed280dc27ce8ab8924"
    },
    {
      "bel": "a(CHEBI:dioxygen)",
      "concept": {
        "name": "dioxygen",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "bbe161dd595b582241898258462de427"
    },
    {
      "bel": "a(CHEBI:doxorubicin)",
      "concept": {
        "name": "doxorubicin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "36b81fc3df19f2c9d3490d3fce5232c9"
    },
    {
      "bel": "a(CHEBI:testosterone)",
      "concept": {
        "name": "testosterone",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "2c9b1a06c737e5a44f65d2aad60b5548"
    },
    {
      "bel": "a(CHEBI:vanillin)",
      "concept": {
        "name": "vanillin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "94908265c1f99f4e753f392cf7304fa5"
    },
    {
      "bel": "a(CONSO:\"amyloid-beta fibrils\")",
      "concept": {
        "name": "amyloid-beta fibrils",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "b0d56b42446bae9f5fb7dbdf434d93af"
    },
    {
      "bel": "a(MESH:\"Anti-Inflammatory Agents\")",
      "concept": {
        "name": "Anti-Inflammatory Agents",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "a9cf39befdc22d33b63e3f87327f3b50"
    },
    {
      "bel": "a(MESH:Alarmins)",
      "concept": {
        "name": "Alarmins",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "7d83a7253d2a03748101be61db841bf7"
    },
    {
      "bel": "a(MESH:Cytokines)",
      "concept": {
        "name": "Cytokines",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "0d3c01297f25a34285f54b350178a231"
    },
    {
      "bel": "a(MESH:Cytoskeleton)",
      "concept": {
        "name": "Cytoskeleton",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "0e4d0b021771899e4e5087eb6ced2278"
    },
    {
      "bel": "a(MESH:Lipofuscin)",
      "concept": {
        "name": "Lipofuscin",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "e5c5553a4dd58db357f05c1f78453174"
    },
    {
      "bel": "a(MESH:Neurons)",
      "concept": {
        "name": "Neurons",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "c429b8780142c504cf23cacfc2fa2b09"
    },
    {
      "bel": "a(MESH:Tissues)",
      "concept": {
        "name": "Tissues",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "892d2cfb80cbe3b7162d067f014e8ad0"
    },
    {
      "bel": "a(PUBCHEM:443101)",
      "concept": {
        "name": "443101",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "d0a4fe6d5e4a23f87ab20a12346963d4"
    },
    {
      "bel": "bp(GO:\"ATP biosynthetic process\")",
      "concept": {
        "name": "ATP biosynthetic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "96df6f1d8c5cfa09f5e6594c902772ae"
    },
    {
      "bel": "bp(GO:\"ATP generation from ADP\")",
      "concept": {
        "name": "ATP generation from ADP",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "434ba9eac17ac3bdef2728d10746d6f9"
    },
    {
      "bel": "bp(GO:\"cell death\")",
      "concept": {
        "name": "cell death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "07a2f2734c3682bcb47105485c15b346"
    },
    {
      "bel": "bp(GO:\"cellular calcium ion homeostasis\")",
      "concept": {
        "name": "cellular calcium ion homeostasis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "281d47ec364551773135033eccfb022b"
    },
    {
      "bel": "bp(GO:\"cellular respiration\")",
      "concept": {
        "name": "cellular respiration",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ced509226a10b89fb0f158c6a90c60c2"
    },
    {
      "bel": "bp(GO:\"cytokine production\")",
      "concept": {
        "name": "cytokine production",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a7cc5a9048ceb3474610a0f305bbbad6"
    },
    {
      "bel": "bp(GO:\"energy homeostasis\")",
      "concept": {
        "name": "energy homeostasis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "d350b37fb24c6e9ace1f29d8faf883ea"
    },
    {
      "bel": "bp(GO:\"establishment or maintenance of transmembrane electrochemical gradient\")",
      "concept": {
        "name": "establishment or maintenance of transmembrane electrochemical gradient",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "21099ff90c427b2a405e77d91d28768a"
    },
    {
      "bel": "bp(GO:\"glycolytic process\")",
      "concept": {
        "name": "glycolytic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "de85d9d53df85cf1d871ae538e4286b3"
    },
    {
      "bel": "bp(GO:\"inflammatory response\")",
      "concept": {
        "name": "inflammatory response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "abd32f6c5cca606061975532840db260"
    },
    {
      "bel": "bp(GO:\"macrophage activation\")",
      "concept": {
        "name": "macrophage activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "b4f30b2d638992803651eb8bd038b5e6"
    },
    {
      "bel": "bp(GO:\"membrane lipid catabolic process\")",
      "concept": {
        "name": "membrane lipid catabolic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "e29cd721ba541e75bbcc84a5a727cc31"
    },
    {
      "bel": "bp(GO:\"necrotic cell death\")",
      "concept": {
        "name": "necrotic cell death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "eb13ddac06fd65b8d7aaab98394d3e5d"
    },
    {
      "bel": "bp(GO:\"programmed cell death\")",
      "concept": {
        "name": "programmed cell death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c46d0518c6a1a11ecf829fc5e3f8bcff"
    },
    {
      "bel": "bp(GO:\"reactive oxygen species biosynthetic process\")",
      "concept": {
        "name": "reactive oxygen species biosynthetic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "1d11672e54abe18a202b96a6ed60d5fc"
    },
    {
      "bel": "bp(GO:angiogenesis)",
      "concept": {
        "name": "angiogenesis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "3d6fd378871feec80135a583c419e7f1"
    },
    {
      "bel": "bp(GO:autophagy)",
      "concept": {
        "name": "autophagy",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "9efc965fac6a195d0fad26eecddaac05"
    },
    {
      "bel": "bp(GO:phagocytosis)",
      "concept": {
        "name": "phagocytosis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "7a964edef32244471f3c9f79c2cdfbaf"
    },
    {
      "bel": "bp(GO:proteolysis)",
      "concept": {
        "name": "proteolysis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c90f282c86a15f55e0daaf157685ceff"
    },
    {
      "bel": "bp(MESH:\"Cell Hypoxia\")",
      "concept": {
        "name": "Cell Hypoxia",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "0cb9101467977ddec2e96bce0906e40e"
    },
    {
      "bel": "complex(GO:\"inflammasome complex\")",
      "concept": {
        "name": "inflammasome complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "5f381d18b57c2a81a9c248759d732dd9"
    },
    {
      "bel": "complex(GO:\"transcription factor AP-1 complex\")",
      "concept": {
        "name": "transcription factor AP-1 complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "a430f30922a2dbff47a0b6dfee881d4c"
    },
    {
      "bel": "complex(a(CONSO:\"amyloid-beta fibrils\"), a(MESH:Alarmins))",
      "function": "Complex",
      "id": "7baff789d711c8464460097a81ef153a",
      "members": [
        {
          "bel": "a(CONSO:\"amyloid-beta fibrils\")",
          "concept": {
            "name": "amyloid-beta fibrils",
            "namespace": "CONSO"
          },
          "function": "Abundance",
          "id": "b0d56b42446bae9f5fb7dbdf434d93af"
        },
        {
          "bel": "a(MESH:Alarmins)",
          "concept": {
            "name": "Alarmins",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "7d83a7253d2a03748101be61db841bf7"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:Alarmins), complex(GO:\"inflammasome complex\"))",
      "function": "Complex",
      "id": "b41844fc82109574c4b7880ed905fc34",
      "members": [
        {
          "bel": "a(MESH:Alarmins)",
          "concept": {
            "name": "Alarmins",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "7d83a7253d2a03748101be61db841bf7"
        },
        {
          "bel": "complex(GO:\"inflammasome complex\")",
          "concept": {
            "name": "inflammasome complex",
            "namespace": "GO"
          },
          "function": "Complex",
          "id": "5f381d18b57c2a81a9c248759d732dd9"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:Alarmins), p(HGNC:AGER))",
      "function": "Complex",
      "id": "10c9f389bc9b68938ff78ab13d8df906",
      "members": [
        {
          "bel": "a(MESH:Alarmins)",
          "concept": {
            "name": "Alarmins",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "7d83a7253d2a03748101be61db841bf7"
        },
        {
          "bel": "p(HGNC:AGER)",
          "concept": {
            "name": "AGER",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "6438987a3f1a4ac86a4360bddbf0bc6a"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:Alarmins), p(HGNC:P2RX7))",
      "function": "Complex",
      "id": "11d0bd966ca47c7bd8c751f61b236843",
      "members": [
        {
          "bel": "a(MESH:Alarmins)",
          "concept": {
            "name": "Alarmins",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "7d83a7253d2a03748101be61db841bf7"
        },
        {
          "bel": "p(HGNC:P2RX7)",
          "concept": {
            "name": "P2RX7",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "ef9224d3c23b90c0a9e47dc46b563ec0"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:Alarmins), p(HGNCGENEFAMILY:\"NLR family\"))",
      "function": "Complex",
      "id": "4ade5c41af429e809d990aef3de17688",
      "members": [
        {
          "bel": "a(MESH:Alarmins)",
          "concept": {
            "name": "Alarmins",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "7d83a7253d2a03748101be61db841bf7"
        },
        {
          "bel": "p(HGNCGENEFAMILY:\"NLR family\")",
          "concept": {
            "name": "NLR family",
            "namespace": "HGNCGENEFAMILY"
          },
          "function": "Protein",
          "id": "d155bc1a327e81a49990c3dd552a96f1"
        }
      ]
    },
    {
      "bel": "complex(p(CONSO:\"amyloid-beta aggregates\"), p(HGNCGENEFAMILY:\"Long pentraxins\"))",
      "function": "Complex",
      "id": "a2aeec4e7a6ee84c25851b995e48d631",
      "members": [
        {
          "bel": "p(CONSO:\"amyloid-beta aggregates\")",
          "concept": {
            "name": "amyloid-beta aggregates",
            "namespace": "CONSO"
          },
          "function": "Protein",
          "id": "cc707e7318711d4e02c0ffa198ca3e34"
        },
        {
          "bel": "p(HGNCGENEFAMILY:\"Long pentraxins\")",
          "concept": {
            "name": "Long pentraxins",
            "namespace": "HGNCGENEFAMILY"
          },
          "function": "Protein",
          "id": "7e22c668895b4395a466a4e3c46fa88a"
        }
      ]
    },
    {
      "bel": "g(HGNC:HK2)",
      "concept": {
        "name": "HK2",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "7d8e40fb23047261ae9f9d1aef09aae1"
    },
    {
      "bel": "g(HGNC:SLC2A1)",
      "concept": {
        "name": "SLC2A1",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "4b4a3e3b35ff9c694d53b5e0033a0cf9"
    },
    {
      "bel": "g(HGNC:TERT)",
      "concept": {
        "name": "TERT",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "252c28cbb89b7fac733603b5a90d5d2e"
    },
    {
      "bel": "g(HGNC:TGFB1)",
      "concept": {
        "name": "TGFB1",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "bc2adb74edfa56453591bdb4585280c9"
    },
    {
      "bel": "g(HGNC:VEGFA)",
      "concept": {
        "name": "VEGFA",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "4424e947db62f911425d65aaed6f76b9"
    },
    {
      "bel": "g(HGNCGENEFAMILY:\"Toll like receptors\")",
      "concept": {
        "name": "Toll like receptors",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Gene",
      "id": "98215bfa77a3312f50a8ef07fa0fca64"
    },
    {
      "bel": "p(CONSO:\"Tau aggregates\")",
      "concept": {
        "name": "Tau aggregates",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "d03adc6b1e424e742ba646d63a61f48e"
    },
    {
      "bel": "p(CONSO:\"amyloid-beta aggregates\")",
      "concept": {
        "name": "amyloid-beta aggregates",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "cc707e7318711d4e02c0ffa198ca3e34"
    },
    {
      "bel": "p(CONSO:\"amyloid-beta fibrils\")",
      "concept": {
        "name": "amyloid-beta fibrils",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "938f339273443c3fc30df2226245890a"
    },
    {
      "bel": "p(CONSO:\"huntingtin aggregates\")",
      "concept": {
        "name": "huntingtin aggregates",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "4cdb1f8f0061623e2b62740b9d08f064"
    },
    {
      "bel": "p(HGNC:AGER)",
      "concept": {
        "name": "AGER",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6438987a3f1a4ac86a4360bddbf0bc6a"
    },
    {
      "bel": "p(HGNC:APCS)",
      "concept": {
        "name": "APCS",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "bfab52d8b2212aa56ad4c23c06031995"
    },
    {
      "bel": "p(HGNC:APP)",
      "concept": {
        "name": "APP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d43ae551265c6b6a27038d0b036848cf"
    },
    {
      "bel": "p(HGNC:B2M)",
      "concept": {
        "name": "B2M",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "466eafb37cece4425f8b1b8dea02bf47"
    },
    {
      "bel": "p(HGNC:BACE1)",
      "concept": {
        "name": "BACE1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "334dd03e9a5f223f13995e497b1c156e"
    },
    {
      "bel": "p(HGNC:BDNF)",
      "concept": {
        "name": "BDNF",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a638d5f84b9678f17c8795852300134a"
    },
    {
      "bel": "p(HGNC:FGA)",
      "concept": {
        "name": "FGA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "bc8ec123cf4fe3c124d004dd893e6089"
    },
    {
      "bel": "p(HGNC:GSN)",
      "concept": {
        "name": "GSN",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8c80b193b1d841e7082ec7bba112397d"
    },
    {
      "bel": "p(HGNC:HIF1A)",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "589a3a55500d0b280fdfeb11b3a4c4b3"
    },
    {
      "bel": "p(HGNC:HK2)",
      "concept": {
        "name": "HK2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "880eb6d272e254f51354af697b542683"
    },
    {
      "bel": "p(HGNC:HMGB1)",
      "concept": {
        "name": "HMGB1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "49cae6a35157605b512bcf8e54c1a60d"
    },
    {
      "bel": "p(HGNC:IGF1)",
      "concept": {
        "name": "IGF1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4089131c84500a626f3306507fbf4b11"
    },
    {
      "bel": "p(HGNC:INSRR)",
      "concept": {
        "name": "INSRR",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "711a668962cfb8acf469d832a677e09d"
    },
    {
      "bel": "p(HGNC:LYZ)",
      "concept": {
        "name": "LYZ",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d203452aaa8535fd822328d0d80f9d2c"
    },
    {
      "bel": "p(HGNC:P2RX7)",
      "concept": {
        "name": "P2RX7",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ef9224d3c23b90c0a9e47dc46b563ec0"
    },
    {
      "bel": "p(HGNC:PROC)",
      "concept": {
        "name": "PROC",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "aef9b9ed1c290227ff978fe51a27fc8f"
    },
    {
      "bel": "p(HGNC:PROC, var(\"?\"))",
      "concept": {
        "name": "PROC",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "53a6e5e5b2585ae77d494d2d8164d778",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SAA1)",
      "concept": {
        "name": "SAA1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ff1dc54b9bfe31cff93d63c49f78f69f"
    },
    {
      "bel": "p(HGNC:SIRT1)",
      "concept": {
        "name": "SIRT1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8170e177ec2e1cce964602b364cab766"
    },
    {
      "bel": "p(HGNC:SLC2A1)",
      "concept": {
        "name": "SLC2A1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0685a7a8e864ce5e9ee91d28f007ba7b"
    },
    {
      "bel": "p(HGNC:STAT3)",
      "concept": {
        "name": "STAT3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "9523cd88bdb7daf4a0aaf38eb43fbe28"
    },
    {
      "bel": "p(HGNC:TTR)",
      "concept": {
        "name": "TTR",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e21b9e732ef5f31c9d4b77e6f9bfd587"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Long pentraxins\")",
      "concept": {
        "name": "Long pentraxins",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "7e22c668895b4395a466a4e3c46fa88a"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"NF-kappa B complex subunits\")",
      "concept": {
        "name": "NF-kappa B complex subunits",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "0a796a3785e4079e00854b3bb4a52785"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"NLR family\")",
      "concept": {
        "name": "NLR family",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "d155bc1a327e81a49990c3dd552a96f1"
    },
    {
      "bel": "p(HGNCGENEFAMILY:Aminopeptidases)",
      "concept": {
        "name": "Aminopeptidases",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "2c736fd3cd90c71a80f8ce8415e61ab8"
    },
    {
      "bel": "p(HGNCGENEFAMILY:Calpains)",
      "concept": {
        "name": "Calpains",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "7ca722526fc0d17a88d8dc58f35706a6"
    },
    {
      "bel": "p(MESH:\"Glycation End Products, Advanced\")",
      "concept": {
        "name": "Glycation End Products, Advanced",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "3bfe191b92f690d06218927bac158066"
    },
    {
      "bel": "p(MESH:\"Matrix Metalloproteinases\")",
      "concept": {
        "name": "Matrix Metalloproteinases",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "77d4d52a4ce564d9659a3134fbd68e16"
    },
    {
      "bel": "p(MESH:\"Prostaglandin-Endoperoxide Synthases\")",
      "concept": {
        "name": "Prostaglandin-Endoperoxide Synthases",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "5300eb40323c150f3de764ddec782dd5"
    },
    {
      "bel": "p(MESH:Deoxyribonucleases)",
      "concept": {
        "name": "Deoxyribonucleases",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "c0c2068fdf606e7185ab416534fa05e0"
    },
    {
      "bel": "p(MESH:Proteins)",
      "concept": {
        "name": "Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "5f95843f75d793290da323632314ec25"
    },
    {
      "bel": "p(MESH:Proteins, pmod(Ac))",
      "concept": {
        "name": "Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "4644265ab2115a09c336098b156bbad9",
      "variants": [
        {
          "concept": {
            "name": "Ac",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MESH:Proteins, pmod(MESH:Polymers))",
      "concept": {
        "name": "Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "b29c008b0a027d13e399f02b6d70f863",
      "variants": [
        {
          "concept": {
            "name": "Polymers",
            "namespace": "MESH"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MESH:Proteins, pmod(Ph))",
      "concept": {
        "name": "Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "2f0178f5fc915758f91f8d2be92322bb",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(NCIT:C16720)",
      "concept": {
        "name": "C16720",
        "namespace": "NCIT"
      },
      "function": "Protein",
      "id": "c99145fd1cdd83abb3408a33c900b625"
    },
    {
      "bel": "p(NCIT:C16720, frag(\"?\"))",
      "concept": {
        "name": "C16720",
        "namespace": "NCIT"
      },
      "function": "Protein",
      "id": "a20c8e17fe99df7cb471004bf75bc6ac",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(NCIT:C706)",
      "concept": {
        "name": "C706",
        "namespace": "NCIT"
      },
      "function": "Protein",
      "id": "0a82c9df915e23fb7d5bd522ddb05562"
    },
    {
      "bel": "p(OMIT:0018975)",
      "concept": {
        "name": "0018975",
        "namespace": "OMIT"
      },
      "function": "Protein",
      "id": "2bc8bb568e89937facf7ff4d8e588434"
    },
    {
      "bel": "path(DOID:\"Alzheimer's disease\")",
      "concept": {
        "name": "Alzheimer's disease",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "bab8638a4ae2b144ee036438e0a858da"
    },
    {
      "bel": "path(DOID:amyloidosis)",
      "concept": {
        "name": "amyloidosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "1461cfaf408aede8aece08a895c6c16b"
    },
    {
      "bel": "path(EFO:\"physical activity\")",
      "concept": {
        "name": "physical activity",
        "namespace": "EFO"
      },
      "function": "Pathology",
      "id": "baa4509c260af69bb969f841aec8c855"
    },
    {
      "bel": "path(EFO:hypoxia)",
      "concept": {
        "name": "hypoxia",
        "namespace": "EFO"
      },
      "function": "Pathology",
      "id": "7b851fa11c82749104da1713c9bda8ef"
    },
    {
      "bel": "path(MESH:Fibrosis)",
      "concept": {
        "name": "Fibrosis",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "dcbee08c082ce3d1f58a75056c14c66f"
    },
    {
      "bel": "path(MESH:Inflammation)",
      "concept": {
        "name": "Inflammation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "10cd96fd4056a5e6c27264e0130e89f9"
    },
    {
      "bel": "path(NCIT:C82901)",
      "concept": {
        "name": "C82901",
        "namespace": "NCIT"
      },
      "function": "Pathology",
      "id": "e7d03a91611c653d6ff16ff44377f366"
    }
  ]
}